| 引用本文： |
-
邵楚楚,王婉莹,任胜祥.CSCO非小细胞肺癌诊疗指南（2021版）解读[J].同济大学学报（医学版）,2022,43(1):1-9. [点击复制]
- SHAO Chuchu,WANG Wanying,REN Shengxiang.Interpretation of Chinese Society of Clinical Oncology(CSCO) Guidelines on Diagnosis and Treatment of Non-Small Cell Lung Cancer(2021 edition)[J].同济大学学报（医学版）,2022,43(1):1-9. [点击复制]
|
|
| 摘要: |
| 《中国临床肿瘤学会（CSCO）非小细胞肺癌诊疗指南（2021版）》已更新发布，新指南整合了过去1年来国内外关于非小细胞肺癌诊断、病理分子检测和治疗手段等方面的进展，以及学术界对2020版指南的反馈意见，可为我国肺癌患者的诊治提供最新依据，以帮助临床医师作出医疗决策。本文就新指南的主要更新要点进行解读。 |
| 关键词: 非小细胞肺癌 指南 诊断 治疗 |
| DOI：10.12289/j.issn.1008-0392.21532 |
| 投稿时间：2021-12-18 |
| 基金项目:上海市浦江人才计划（2019PJD048）；上海市优秀学术带头人（21XD1423200）；上海市肺科医院骨干计划（FKGG1802） |
|
| Interpretation of Chinese Society of Clinical Oncology(CSCO) Guidelines on Diagnosis and Treatment of Non-Small Cell Lung Cancer(2021 edition) |
| SHAO Chuchu,WANG Wanying,REN Shengxiang |
| (School of Medicine, Tongji University, Shanghai 200092, China; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China) |
| Abstract: |
| The Chinese Society of Clinical Oncology(CSCO) Guidelines on Diagnosis and Treatment of Non-Small Cell Lung Cancer were updated in 2021. On the basis of 2020 guidelines, the new guidelines were modified according to domestic and international research progress in the diagnosis, molecular detection, and therapeutic strategies of non-small cell lung cancer, to provide the latest evidence facilitating physicians to make clinical decisions for diagnosis and treatment of lung cancer patients in China. This article interprets the main updated points of the new guidelines. |
| Key words: non-small cell lung cancer guidelines diagnosis treatment |
